FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Direct Rx Simvastatin Recall

Simvastatin, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle

Direct Rx · Dawsonville, GA

Risk level
Class II
Reported by FDA
Apr 5, 2023
Recall ID
D-0483-2023
Check your lot numberHow we source this data

Summary

Direct Rx recalled Simvastatin starting Mar 13, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0483-2023 on Apr 5, 2023. Reason: cGMP deviations. Status: Terminated.

Why it was recalled

cGMP deviations

Product description

Simvastatin, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0710-90 Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534

Lot numbers, UPCs & expiration codes

Lot, expiry: 03JA2209, 28FE2225, 28AP2211, 07AP2203, exp 6/30/23

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0483-2023
Classification
Class II
Status
Terminated
Recall initiated
Mar 13, 2023
FDA report date
Apr 5, 2023
Quantity
51 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Direct Rx

Original FDA data

Every field from FDA enforcement report D-0483-2023, exactly as published.

Show all FDA fields
City
Dawsonville
State
GA
Status
Terminated
Country
United States
Event ID
91921
Address
94 Worldwide Dr
Code information
Lot, expiry: 03JA2209, 28FE2225, 28AP2211, 07AP2203, exp 6/30/23
Postal code
30534-6828
Report date
Apr 5, 2023
Product type
Drugs
Recall number
D-0483-2023
Classification
Class II
Recalling firm
Direct Rx
Product quantity
51 bottles
Termination date
Jun 17, 2024
Reason for recall
cGMP deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
Simvastatin, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0710-90 Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534
Distribution pattern
Nationwide in the USA
Recall initiation date
Mar 13, 2023
Initial firm notification
Letter
Center classification date
Mar 24, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0483-2023, published Apr 5, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls